MA05.071, Remote Electrical Neuromodulation for Migraines
Summary
Independence Blue Cross reissued MA05.071 with no substantive changes to Remote Electrical Neuromodulation (REN/Nerivio) coverage for migraine prevention. The policy establishes medical necessity criteria for adults (18+) and pediatric patients (8-17) with 6-24 headache days per 28-day period, requiring either failed preventive medications, pregnancy/breastfeeding status, medication overuse headache risk, or drug-drug interaction concerns. Acute migraine treatment remains non-covered (experimental/investigational). Billing teams must ensure claims comply with these eligibility criteria and HCPCS code A4540 is used for device billing.
Get alerts when payers change rules like this one
We check Independence Blue Cross and other payers every day and email you when a change matches your specialty and state.